NHS England Unveils Five-Year Genomic Healthcare Strategy
The new strategy places genomics at the heart of a new effort to deliver a sustainable model of healthcare for patients.
At the inaugural International Conference on Newborn Sequencing (ICoNS) in Boston last week, researchers outlined plans from eight studies in the US, the UK, Europe, and Australia.
With rapid nanopore whole-genome sequencing and targeted analysis, researchers can determine a newborn's genetic risk for a disorder in three hours.
Along with partners Genome Medical and Invitae, HNF has launched the CMT Genie Project to improve diagnosis and potentially treatment of Charcot-Marie-Tooth disease.
The molecular diagnostics and bioinformatics firm reduced its 2022 forecast as it reported a 23 percent year-over-year revenue decline in Q2.